Cargando…
A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656359/ https://www.ncbi.nlm.nih.gov/pubmed/33209443 http://dx.doi.org/10.21037/jtd-20-1733 |
| _version_ | 1783608365460488192 |
|---|---|
| author | Cortellini, Alessio Ficorella, Corrado Crisci, Roberto Divisi, Duilio |
| author_facet | Cortellini, Alessio Ficorella, Corrado Crisci, Roberto Divisi, Duilio |
| author_sort | Cortellini, Alessio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7656359 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76563592020-11-17 A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients Cortellini, Alessio Ficorella, Corrado Crisci, Roberto Divisi, Duilio J Thorac Dis Editorial Commentary AME Publishing Company 2020-10 /pmc/articles/PMC7656359/ /pubmed/33209443 http://dx.doi.org/10.21037/jtd-20-1733 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Cortellini, Alessio Ficorella, Corrado Crisci, Roberto Divisi, Duilio A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients |
| title | A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients |
| title_full | A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients |
| title_fullStr | A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients |
| title_full_unstemmed | A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients |
| title_short | A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients |
| title_sort | reflection on the actual place of osimertinib in the treatment algorithm of egfr-positive non-small cell lung cancer patients |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656359/ https://www.ncbi.nlm.nih.gov/pubmed/33209443 http://dx.doi.org/10.21037/jtd-20-1733 |
| work_keys_str_mv | AT cortellinialessio areflectionontheactualplaceofosimertinibinthetreatmentalgorithmofegfrpositivenonsmallcelllungcancerpatients AT ficorellacorrado areflectionontheactualplaceofosimertinibinthetreatmentalgorithmofegfrpositivenonsmallcelllungcancerpatients AT crisciroberto areflectionontheactualplaceofosimertinibinthetreatmentalgorithmofegfrpositivenonsmallcelllungcancerpatients AT divisiduilio areflectionontheactualplaceofosimertinibinthetreatmentalgorithmofegfrpositivenonsmallcelllungcancerpatients AT cortellinialessio reflectionontheactualplaceofosimertinibinthetreatmentalgorithmofegfrpositivenonsmallcelllungcancerpatients AT ficorellacorrado reflectionontheactualplaceofosimertinibinthetreatmentalgorithmofegfrpositivenonsmallcelllungcancerpatients AT crisciroberto reflectionontheactualplaceofosimertinibinthetreatmentalgorithmofegfrpositivenonsmallcelllungcancerpatients AT divisiduilio reflectionontheactualplaceofosimertinibinthetreatmentalgorithmofegfrpositivenonsmallcelllungcancerpatients |